Allogene Therapeutics Inc...
(ALLO)
undefined
undefined%
At close: undefined
1.94
2.92%
After-hours Dec 13, 2024, 06:59 PM EST
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts,
total investments, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| Cash & Equivalents | 83.16M | 576.47M | 809.48M | 1.03B | 588.86M | 721.35M | - |
| Short-Term Investments | 365.54M | 455.42M | 283.99M | 644.56M | 355.41M | 366.95M | - |
| Long-Term Investments | 3.65M | 59.15M | 370.18M | 207.95M | 63.21M | 261.97M | - |
| Other Long-Term Assets | 16.90M | 32.67M | -322.05M | 14.62M | 8.92M | 1.54M | - |
| Receivables | - | - | - | - | 2.40M | 3.11M | - |
| Inventory | - | -62.45M | -20.02M | -207.01M | -60.73M | -261.97M | - |
| Other Current Assets | 10.42M | 11.50M | 8.02M | 10.62M | 11.64M | 5.49M | - |
| Total Current Assets | 459.12M | 528.82M | 809.48M | 845.13M | 544.58M | 467.98M | - |
| Property-Plant & Equipment | 163.18M | 196.43M | 181.02M | 160.13M | 100.94M | 41.61M | - |
| Goodwill & Intangibles | - | - | - | - | 151.00K | 754.00K | - |
| Total Long-Term Assets | 183.72M | 288.25M | 229.15M | 382.70M | 173.23M | 305.87M | - |
| Total Assets | 642.84M | 817.08M | 1.04B | 1.23B | 717.80M | 773.86M | - |
| Account Payables | 5.90M | 13.89M | 10.26M | 10.39M | 9.25M | 12.34M | - |
| Deferred Revenue | 86.00K | 885.00K | 423.00K | 38.99M | - | - | - |
| Short-Term Debt | 6.78M | 6.00M | 3.20M | 2.97M | 1.68M | - | - |
| Other Current Liabilities | 24.32M | 33.84M | 34.72M | 41.96M | 22.15M | 17.12M | 2.00K |
| Total Current Liabilities | 37.08M | 54.52M | 48.17M | 94.32M | 33.08M | 29.46M | 2.00K |
| Long-Term Debt | 88.35M | 95.12M | 69.93M | 50.81M | 51.35M | 34.46M | - |
| Other Long-Term Liabilities | 5.18M | 5.85M | 4.13M | 3.08M | 4.35M | 6.78M | - |
| Total Long-Term Liabilities | 93.53M | 96.69M | 74.05M | 53.89M | 55.70M | 41.23M | - |
| Total Liabilities | 130.60M | 151.21M | 122.23M | 148.21M | 88.78M | 70.69M | 2.00K |
| Total Debt | 95.12M | 95.12M | 69.93M | 53.78M | 51.35M | 34.46M | - |
| Common Stock | 169.00K | 144.00K | 142.00K | 140.00K | 124.00K | 121.00K | 26.00K |
| Retained Earnings | -1.56B | -1.24B | -903.35M | -646.34M | -396.12M | -211.53M | -23.00K |
| Comprehensive Income | -955.00K | -9.93M | -2.57M | 268.00K | 1.15M | 306.00K | -5.00K |
| Shareholders Equity | 512.23M | 665.87M | 916.41M | 1.08B | 629.02M | 703.16M | -2.00K |
| Total Investments | 369.19M | 514.57M | 654.17M | 852.50M | 418.62M | 628.92M | - |